December 25, 2024 08:26 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Former home secy Ajay Kumar Bhalla appointed Manipur Guv amid ethnic violence resurgence | Five soldiers killed, several injured as Army truck falls into Poonch gorge | Allu Arjun quizzed by police in Pushpa 2 stampede case | Wanted Indian drug smuggler killed in the US | Congress leader files complaint against Allu Arjun for 'insulting police' in Pushpa 2: The Rule | Ahead of Jaishankar's US visit, foreign secretary Vikram Misri meets top US diplomats | India refrains from commenting on extradition request for ousted Bengladeshi PM Sheikh Hasina | I don't blame Allu Arjun, ready to withdraw case: Pushpa 2 stampede victim's husband | Indian New Wave Cinema Architect Shyam Benegal dies at age 90 | Cylinder blast at a temple in Karnataka's Hubbali injures nine people
Glenmark's shares surge after getting government approval for Covid-19 drug

Glenmark's shares surge after getting government approval for Covid-19 drug

Jun 22, 2020, at 12:34 pm

Mumbai/IBNS: The shares of Glenmark Pharmaceuticals on Monday surged days after getting an approval from the Drugs Controller General of India (DCGI) to market and manufacture antiviral drug Favipiravir, to be sold under the brand name FabiFlu, for the treatment of Covid-19 patients having mild to moderate symptoms.